Edurant
2 Novel HIV Drugs Look Promising
ViiV Healthcare reported interim results for two investigational HIV medications—both look promising.
NOVEMBER 15, 2018

FDA Approves Juluca, First 2-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV-1 ...
NOVEMBER 22, 2017

New Injectable ART May Increase Effectiveness, Adherence Over Standard Oral Therapy
Intramuscular ART that can be given every four or eight weeks appears to be as effective as current oral ...
AUGUST 22, 2017

2-Drug Combination Effective in Maintaining Viral Suppression in HIV Patients
The requirement of lifelong treatment for HIV infection has highlighted a need to minimize cumulative drug ...
FEBRUARY 17, 2017
